#Scicomm Adding just a small bit to a protein may be the key to broadly improving CAR T and NK cell #immunotherapies. Learn more from new research at St. Jude:

Hey - my recent blog on the FREE resources St. Jude provides for data analysis and visualization. #dataviz

A molecular train has been hard to catch. But clever St. Jude scientists found a way to capture it at high resolution, with implications for a host of diseases #scicomm #sciencecommunication

Childhood cancer survivors who received a low chest radiation and anthracycline dose are not at a heightened risk of heart problems. Read in The Lancet Oncology why Dr. Matthew Ehrhardt says, "We no longer recommend surveillance echocardiograms." bit.ly/3xrUhsS #SurvOnc

Talking about a specific receptor that messes with many FDA-approved drugs can be tricky. Read the release to see how I tried to navigate it #scicomm

Researchers at St. Jude have developed an algorithm inspired by evolutionary principles to design new protein pairs that interact exclusively. Read the blog post to learn how this will improve science and medicine. M. Madan Babu Duccio Malinverni bit.ly/3ZBy9sr

Metastatic cancer cells find ways to thrive in harsh environments. Scientists at St. Jude have new clues about how those cells succeed and how to potentially stop them. bit.ly/3ZUjLvN Science Advances

Scientists from St. Jude and Rockefeller University integrated structural biology techniques to better understand the cystic fibrosis transmembrane conductance regulator, providing new treatment clues. bit.ly/3LKSQ1i Scott C Blanchard #RareDisease nature

Technology from the St. Jude Single-Molecule Imaging Center helped scientists at St. Jude and Rockefeller University gain new insight into how the cystic fibrosis transmembrane conductance regulator works. Read the nature paper. bit.ly/3Txrv4t Scott C Blanchard #RareDisease

#Scicomm moment - including awesome graphics always helps. The SciComm graphic designers knocked this out of the park.

This past year's RSV season was historically bad. Discover how St. Jude is tackling RSV and infectious diseases research to protect vulnerable children. #scicomm

Influenza H3N2 viruses are often poorly matched by the seasonal flu vaccine due to destabilizing mutations in hemagglutinin. Read the Science Advances study to discover how stabilizing this protein may improve vaccines and pandemic predictions. bit.ly/40rDFhI

Two genes can fuse, creating an oncogenic fusion that drives cancer. Scientists characterized these fusions in pediatric cancer. Learn how it improved disease predictions and may lead to CRISPR-based treatments. bit.ly/3KzATS1 Nature Communications #PrecisionMedicine

Good science is simple. This approach directly fixes the mutation that causes sickle cell disease. This was a much easier #scicomm piece, because the result is very intuitive.

St. Jude upgraded a computational tool (NetBID2) to find hidden drivers of disease by getting more information out of large multi-omics datasets. Explore how the tool can fuel new clinical trials with FDA-approved drugs. bit.ly/44vgGop Nature Communications Jiyang Yu

When people think of virology, they rarely think of a week at the beach. But for the last 38 years, St. Jude avian flu hunters have traveled to Delaware Bay to collect bird poop which, this year, will help provide context for the ongoing pandemic. bit.ly/43DRV8K

#scicomm at its finest!

We're excited to share our latest study on how the lysosomal adaptor JIP3 and regulatory protein LIS1 activate dynein-dynactin. Out now on bioRxiv! Work done by Kashish Singh Clinton Lau Giulia Manigrasso in collaboration with Reto Gassmann lab. (1/6) biorxiv.org/content/10.110…

Avian influenza, fatal in birds, found in U.S. dairy cattle for the first time in Texas and Kansas. St. Jude virologists weigh in on the global bird flu outbreak, #H5N1 and the future of flu surveillance. Read more The New York Times. bit.ly/3IWMkSl

Newly discovered non-coding genetic variants contributing to chemotherapy resistance in acute lymphoblastic leukemia may help increase understanding of a wide set of biological traits and diseases beyond chemotherapy resistance. bit.ly/3UIxhCt